Prednisone Recruiting Phase 1 Trials for Burkitt's Lymphoma / Non-Hodgkin's Lymphoma (NHL) / Malignant Lymphomas / Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03223610Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma